Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.01

-0.68

-0.34

-0.01

Details

Expected EPS

-0.132857

Actual EPS

-0.13

Surprise EPS

0

Surprise Percent

+2.15%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.13 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.